AF Symposium 2024 Late-Breaking Science Collection
Published: 19 February 2024
-
Views:
1692
-
Likes:
7
-
Views:
1692
-
Likes:
7
-
7m 33sPart 1 3 Studies that Will Change Your Practice with Prof Angelo Auricchio Angelo Auricchio
-
2m 9sPart 2 | Session 1 MANIFEST-PF: Impact of LAPW Ablation During PFA for Persistent AF Mohit K Turagam
-
4m 16sPart 2 | Session 2 Long-Term Effects of Pulsed Field Ablation on Coronary Arteries Yury Malyshev
-
4m 13sPart 2 | Session 3 EASY AF: Esophagus Deviation During Radiofrequency Ablation of AF Emile Daoud
-
9m 49sPart 2 | Session 4 aMAZE CAP: LAA Exclusion in Addition to PVI for Non-paroxysmal AFIB Dhanunjaya Lakkireddy
Overview
Short, accessible Expert Interviews were conducted with investigators focusing on study design, key results and applicability of the latest data.
More from this programme
Part 1
Highlights
Part 2
Expert Interviews
About the episode
AF Symposium 2024 – In this interview, Dr Christopher R Ellis (Vanderbilt University Medical Center, US) joins us to discuss the early findings from the EMERGE LAA Post-Approval Study.
The study investigated the early postapproval outcomes of the Amulet occluder device within the United States, using data from the Left Atrial Appendage Occlusion Registry.
Questions:
- What is the background of this study?
- Can you please tell us about the study device?
- What was the methodology of this study?
- What data did you present at AFSymposium?
- What are the key messages for practice?
- What are the next steps?
Recorded on-site at AF Symposium, Boston 2024.
Editor: Mirjam Boros
Videography: David Ramsey, Brad Wilson, William Cadden, Mike Knight
Comments